Biomarkers in axial spondyloarthritis diagnosis: from clinical signs to multi-omics integration.

Xin P, Xu Z, Pan Y, Zhang M, Wang R

Open source

DOI
10.3389/fimmu.2026.1929862
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1929862,
  title = {Biomarkers in axial spondyloarthritis diagnosis: from clinical signs to multi-omics integration.},
  author = {Xin P and Xu Z and Pan Y and Zhang M and Wang R},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1929862},
  url = {https://doi.org/10.3389/fimmu.2026.1929862}
}

RIS

TY  - JOUR
TI  - Biomarkers in axial spondyloarthritis diagnosis: from clinical signs to multi-omics integration.
AU  - Xin P
AU  - Xu Z
AU  - Pan Y
AU  - Zhang M
AU  - Wang R
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1929862
UR  - https://doi.org/10.3389/fimmu.2026.1929862
ER  - 

APA

P, X., Z, X., Y, P., M, Z., & R, W. (2026). Biomarkers in axial spondyloarthritis diagnosis: from clinical signs to multi-omics integration.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1929862

Source records